The following pages link to Yingye Zheng (Q246366):
Displaying 31 items.
- Evaluating incremental values from new predictors with net reclassification improvement in survival analysis (Q746472) (← links)
- Adopting nested case-control quota sampling designs for the evaluation of risk markers (Q746492) (← links)
- Evaluating the ROC performance of markers for future events (Q1029793) (← links)
- Analyses of preventive care measures with incomplete historical data in electronic medical records: an example from colorectal cancer screening (Q2194491) (← links)
- Improving efficiency in biomarker incremental value evaluation under two-phase designs (Q2404431) (← links)
- Assessing incremental value of biomarkers with multi-phase nested case-control studies (Q2809548) (← links)
- Evaluating prognostic accuracy of biomarkers in nested case-control studies (Q2893221) (← links)
- Evaluating Prognostic Accuracy of Biomarkers under Competing Risk (Q2912330) (← links)
- Robust Prediction of t-Year Survival with Data from Multiple Studies (Q3013973) (← links)
- Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies (Q3095176) (← links)
- The sensitivity and specificity of markers for event times (Q3434133) (← links)
- Semiparametric Models of Time-Dependent Predictive Values of Prognostic Biomarkers (Q3561800) (← links)
- Application of Multidimensional Selective Item Response Regression Model for Studying Multiple Gene Methylation in SV40 Oncogenic Pathways (Q3632631) (← links)
- Time-Dependent Predictive Values of Prognostic Biomarkers With Failure Time Outcome (Q3632645) (← links)
- Evaluating the Predictive Value of Biomarkers with Stratified Case‐Cohort Design (Q4911947) (← links)
- Nonparametric Maximum Likelihood Estimators of Time-Dependent Accuracy Measures for Survival Outcome Under Two-Stage Sampling Designs (Q4962452) (← links)
- Evaluating Incremental Values from New Predictors with Net Reclassification Improvement in Survival Analysis (Q4984857) (← links)
- Learning‐based biomarker‐assisted rules for optimized clinical benefit under a risk constraint (Q4998692) (← links)
- Semiparametric estimation of time-dependent ROC curves for longitudinal marker data (Q5313532) (← links)
- On longitudinal prediction with time‐to‐event outcome: Comparison of modeling options (Q5347405) (← links)
- Resampling Procedures for Making Inference Under Nested Case–Control Studies (Q5406378) (← links)
- Model Checking for ROC Regression Analysis (Q5427412) (← links)
- Prospective Accuracy for Longitudinal Markers (Q5459574) (← links)
- Application of the Time‐Dependent ROC Curves for Prognostic Accuracy with Multiple Biomarkers (Q5473236) (← links)
- Partly Conditional Survival Models for Longitudinal Data (Q5714620) (← links)
- Survival Model Predictive Accuracy and ROC Curves (Q5715356) (← links)
- Subgroup specific incremental value of new markers for risk prediction (Q5963059) (← links)
- New weighting methods when cases are only a subset of events in a nested case‐control study (Q6068832) (← links)
- Developing and evaluating risk prediction models with panel current status data (Q6074506) (← links)
- Constructing dynamic treatment regimes with shared parameters for censored data (Q6627322) (← links)
- Biomarker evaluation under imperfect nested case-control design (Q6628423) (← links)
